Takashi Kanbayashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Takashi Kanbayashi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Haruko Tsukamoto
Department of Pediatrics, Nagoya City University Medical School, Nagoya, Japan
1 shared publicationRika Aizawa
Department of Neuropsychiatry, Akita University School of Medicine, Akita, Japan
1 shared publicationSeiji Nishino
Center for Narcolepsy, Stanford University School of Medicine, CA, USA
1 shared publicationShigeru Chiba
Department of Neuropsychiatry, Asahikawa Medical College, Asahikawa, Japan
1 shared publicationTetsuo Shimizu
Department of Neuropsychiatry, Akita University School of Medicine, Akita, Japan
1 shared publicationYasushi Saito
Department of Neuropsychiatry, Akita University School of Medicine, Akita, Japan
1 shared publication
Latest Publications
- Open Access
- 28 February 2002
- Published by Wiley in Journal of Sleep Research
- Vol. 11 (1) , 91-93
CSF hypocretin‐1 (orexin‐A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia
We measured cerebrospinal fluid (CSF) hypocretin‐1 levels in 11 patients with narcolepsy–cataplexy, five with narcolepsy without cataplexy and 12 with idiopathic hypersomnia (IHS). All patients were Japanese. As reported in Caucasian patients, undetectable or very low hypocretin‐1 levels were observed in most (9 out of 11) Japanese narcolepsy–cataplexy patients. Our hypocretin‐deficient narcoleptics included three prepubertal cases within few months after the disease onset. All nine hypocretin‐deficient patients were human leuckocyte antigen (HLA) DR2 positive, while two who had normal CSF hypocretin‐1 levels were HLA DR2 negative. In contrast, none of the narcolepsy without cataplexy and IHS subjects had undetectable low levels. Low CSF hypocretin‐1 is therefore very specific for HLA DR2 positive narcolepsy–cataplexy, and the deficiency is likely to be established at the early stage of the disease.
- 28 February 2002
- Published by Wiley in Journal of Sleep Research
- Vol. 11 (1) , 91-93
Open AccessCSF hypocretin‐1 (orexin‐A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia
We measured cerebrospinal fluid (CSF) hypocretin‐1 levels in 11 patients with narcolepsy–cataplexy, five with narcolepsy without cataplexy and 12 with idiopathic hypersomnia (IHS). All patients were Japanese. As reported in Caucasian patients, undetectable or very low hypocretin‐1 levels were observed in most (9 out of 11) Japanese narcolepsy–cataplexy patients. Our hypocretin‐deficient narcoleptics included three prepubertal cases within few months after the disease onset. All nine hypocretin‐deficient patients were human leuckocyte antigen (HLA) DR2 positive, while two who had normal CSF hypocretin‐1 levels were HLA DR2 negative. In contrast, none of the narcolepsy without cataplexy and IHS subjects had undetectable low levels. Low CSF hypocretin‐1 is therefore very specific for HLA DR2 positive narcolepsy–cataplexy, and the deficiency is likely to be established at the early stage of the disease.